Skip to main content

Advertisement

Table 1 Characteristics of the human study population (n = 41)

From: Aptamer-based search for correlates of plasma and serum water T2: implications for early metabolic dysregulation and metabolic syndrome

Parameter Mean ± S.D. Range Reference Valuesa
Age 36.5 ± 12.5 23–61 n/a
Gender n/a 19 female, 22 male n/a
Body-Mass Index (kg/m2) 26.5 ± 5.5 19.1–45.1 < 25 normal weight, 25–30 overweight, > 30 obese
Plasma T2 (ms) 771.5 ± 58.3 631–887 ≥ 745.0b
Serum T2 (ms) 817.4 ± 5.2 706–908 ≥ 811.8b
Glucose (mg/dL) 90.6 ± 7.7 71–109 < 100 non-diabetic
100–125 (pre-diabetic)
HbA1c (%) 5.5 ± 0.3 4.7–6.1 < 5.7 (non-diabetic)
5.7–6.4 (pre-diabetic)
Insulin C-peptide (ng/mL) 1.8 ± 0.8 0.7–5.1 0.8–3.9 (> 2.85, IRc)
Insulin (μU/mL) 8.7 ± 6.6 2.2–40.1 2.0–19.6 (> 12.2, IRc)
Total serum protein (g/dL) 7.2 ± 0.4 6.3–8.0 6.1–8.1
Serum albumin (g/dL) 4.5 ± 0.3 3.6–5.1 3.6–5.1
Serum globulins (g/dL) 2.7 ± 0.3 1.9–3.3 1.9–3.7
Triglycerides (mg/dL) 123 ± 63.1 50–321 < 150
Total cholesterol (mg/dL) 185.0 ± 45.0 97–291 < 200
HDL-C (mg/dL) 51.7 ± 12.7 31–78 ≥ 40 (male); ≥ 50 (female)
LDL-C (mg/dL) 110.1 ± 35.9 50–191 < 130
WBC count (× 103/μL) 6.6 ± 1.7 3.9–11.2 3.8–10.8
Neutrophil count (× 103/μL) 3.6 ± 1.2 1.8–7.2 1.5–7.8
hs-CRP (mg/L) 2.6 ± 2.7 0.1–9.6 < 3.0 (low/average CV risk)
3.0–10.0 (high CV risk)
> 10.0 (infection/illness)
Sodium (mmoles/L) 138.2 ± 2.6 131–143 135–146
Potassium (mmoles/L) 4.1 ± 0.3 3.7–4.8 3.5–5.3
Total CO2, (mmoles/L) 24.2 ± 2.3 18–28 19–30
  1. aReference values from Quest Diagnostics and Atherotech, except where noted
  2. bCutoff for normoglycemic population established in previous study [8]
  3. cInsulin cutoff from McAuley et al. [67]; insulin C-peptide cutoff established by linear regression with insulin